NEW YORK (GenomeWeb) – Proteome Sciences said today it has raised £3.3 million ($4.0 million) in new funding.

The company plans to use the money to speed its transition to a contract research business model, and to ensure it has the capacity to meet demand from Thermo Fisher Scientific for its TMT isobaric tagging reagents, to which Thermo Fisher has the license.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.

Sponsored by

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.